vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and Ranpak Holdings Corp. (PACK). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $93.7M, roughly 1.6× Ranpak Holdings Corp.). On growth, Ranpak Holdings Corp. posted the faster year-over-year revenue change (2.3% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 13.7%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...
NUTX vs PACK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $93.7M |
| Net Profit | $11.8M | — |
| Gross Margin | 30.4% | 39.0% |
| Operating Margin | 20.4% | -1.0% |
| Net Margin | 7.8% | — |
| Revenue YoY | -41.1% | 2.3% |
| Net Profit YoY | -80.8% | — |
| EPS (diluted) | $2.34 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $93.7M | ||
| Q3 25 | $267.8M | $83.6M | ||
| Q2 25 | $244.0M | $77.8M | ||
| Q1 25 | $211.8M | $77.6M | ||
| Q4 24 | $257.6M | $91.6M | ||
| Q3 24 | $78.8M | $78.6M | ||
| Q2 24 | $76.1M | $72.8M | ||
| Q1 24 | $67.5M | $72.5M |
| Q4 25 | $11.8M | — | ||
| Q3 25 | $55.4M | $-10.4M | ||
| Q2 25 | $-17.7M | $-7.5M | ||
| Q1 25 | $21.2M | $-10.9M | ||
| Q4 24 | $61.6M | — | ||
| Q3 24 | $-8.8M | $-8.1M | ||
| Q2 24 | $-364.0K | $5.5M | ||
| Q1 24 | $-364.0K | $-8.1M |
| Q4 25 | 30.4% | 39.0% | ||
| Q3 25 | 57.8% | 41.1% | ||
| Q2 25 | 51.2% | 37.1% | ||
| Q1 25 | 55.9% | 39.8% | ||
| Q4 24 | 55.0% | 45.2% | ||
| Q3 24 | 27.8% | 43.8% | ||
| Q2 24 | 29.7% | 43.5% | ||
| Q1 24 | 15.1% | 44.6% |
| Q4 25 | 20.4% | -1.0% | ||
| Q3 25 | 48.7% | -6.8% | ||
| Q2 25 | 13.8% | -12.5% | ||
| Q1 25 | 38.1% | -10.3% | ||
| Q4 24 | 44.4% | 1.5% | ||
| Q3 24 | 12.3% | -5.3% | ||
| Q2 24 | 7.0% | -7.1% | ||
| Q1 24 | 2.1% | -6.6% |
| Q4 25 | 7.8% | — | ||
| Q3 25 | 20.7% | -12.4% | ||
| Q2 25 | -7.3% | -9.6% | ||
| Q1 25 | 10.0% | -14.0% | ||
| Q4 24 | 23.9% | — | ||
| Q3 24 | -11.2% | -10.3% | ||
| Q2 24 | -0.5% | 7.6% | ||
| Q1 24 | -0.5% | -11.2% |
| Q4 25 | $2.34 | $-0.11 | ||
| Q3 25 | $7.76 | $-0.12 | ||
| Q2 25 | $-2.95 | $-0.09 | ||
| Q1 25 | $3.33 | $-0.13 | ||
| Q4 24 | $11.56 | $-0.13 | ||
| Q3 24 | $-1.72 | $-0.10 | ||
| Q2 24 | $-0.07 | $0.07 | ||
| Q1 24 | $-0.08 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $63.0M |
| Total DebtLower is stronger | — | $401.9M |
| Stockholders' EquityBook value | $329.4M | $534.9M |
| Total Assets | $918.5M | $1.1B |
| Debt / EquityLower = less leverage | — | 0.75× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $63.0M | ||
| Q3 25 | $166.0M | $49.9M | ||
| Q2 25 | $96.7M | $49.2M | ||
| Q1 25 | $84.7M | $65.5M | ||
| Q4 24 | $40.6M | $76.1M | ||
| Q3 24 | $46.9M | $69.5M | ||
| Q2 24 | $40.8M | $65.1M | ||
| Q1 24 | $30.0M | $55.1M |
| Q4 25 | — | $401.9M | ||
| Q3 25 | — | $403.1M | ||
| Q2 25 | — | $403.1M | ||
| Q1 25 | — | $405.2M | ||
| Q4 24 | — | $406.4M | ||
| Q3 24 | — | $403.2M | ||
| Q2 24 | — | $396.1M | ||
| Q1 24 | — | $396.7M |
| Q4 25 | $329.4M | $534.9M | ||
| Q3 25 | $317.2M | $537.8M | ||
| Q2 25 | $235.3M | $539.0M | ||
| Q1 25 | $176.9M | $544.1M | ||
| Q4 24 | $132.4M | $548.1M | ||
| Q3 24 | $60.4M | $564.3M | ||
| Q2 24 | $62.7M | $566.2M | ||
| Q1 24 | $63.0M | $560.0M |
| Q4 25 | $918.5M | $1.1B | ||
| Q3 25 | $964.5M | $1.1B | ||
| Q2 25 | $841.0M | $1.1B | ||
| Q1 25 | $761.9M | $1.1B | ||
| Q4 24 | $655.3M | $1.1B | ||
| Q3 24 | $438.5M | $1.1B | ||
| Q2 24 | $422.4M | $1.1B | ||
| Q1 24 | $404.3M | $1.1B |
| Q4 25 | — | 0.75× | ||
| Q3 25 | — | 0.75× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.71× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.71× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $19.5M |
| Free Cash FlowOCF − Capex | $69.0M | — |
| FCF MarginFCF / Revenue | 45.5% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | 5.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $19.5M | ||
| Q3 25 | $99.5M | $8.5M | ||
| Q2 25 | $27.3M | $-3.6M | ||
| Q1 25 | $51.0M | $-1.3M | ||
| Q4 24 | $54.0K | $6.5M | ||
| Q3 24 | $6.8M | $10.1M | ||
| Q2 24 | $13.3M | $19.6M | ||
| Q1 24 | $3.1M | $5.2M |
| Q4 25 | $69.0M | — | ||
| Q3 25 | $99.2M | — | ||
| Q2 25 | $26.5M | — | ||
| Q1 25 | $50.9M | — | ||
| Q4 24 | $-341.0K | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $12.7M | — | ||
| Q1 24 | $2.3M | — |
| Q4 25 | 45.5% | — | ||
| Q3 25 | 37.0% | — | ||
| Q2 25 | 10.9% | — | ||
| Q1 25 | 24.0% | — | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 16.7% | — | ||
| Q1 24 | 3.4% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 1.1% | — |
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.56× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
PACK
| Other | $47.9M | 51% |
| Europe And Asia Segment | $45.8M | 49% |
